Presidential Communications Operations Office

  PIA Bldg, Visayas Ave, Diliman, Quezon City, Philippines
  Monday, 10 August 2020 News Before 1 Feb 2012. Click for Latest
Web PIA  
 << August 2020 >> 
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31
Special News Editions:
PIA Specials:
NEW! Cabinet Officials
Jobs.Slides.Specials.Ads. Events.ASEAN.Multimedia
Visitors since 15 Feb 2011:
PIA News Archive:
PIA Archive News Reader

PIA Press Release

Philhealth expands coverage for medicines under P100 Program

by Juliet B. Saley

Bontoc, Mt. Province (20 June) -- To ensure access to cheaper quality drugs and medicines for illnesses significantly affecting the health of Filipinos particularly the marginalized sector, the Philhealth expanded the coverage for drugs and medicines to include take home medications under the P100 Program beyond the patient's confinement period as take home medication.

PhilHealth Circular No. 20,S. 2009 was issued by Dr. Rey B. Aquino, President of the Philippine Health Insurance Corporation (PHIC) regarding the PhilHealth coverage of P100 Drugs and medicines for eligible sponsored members.

P100 Project is initiated by the Department of Health that would ensure access to drugs which are packaged within an affordability parameter of P100.00 or lower which shall be piloted in 100 hospitals (DOH and selected LGUs), of which Mt. Province is included.

This benefit shall initially cover all eligible sponsored members and their qualified dependents with dates of confinement within the validity period of their membership as indicated in the ID card/Member Data Record.. Benefit claims takes effect with admission date starting June 1, 2009.

P100 drugs shall be presented to sponsored members, as applicable, during confinement and extra packs needed beyond the confinement period subject to the following limitations like full course treatment which is maximum of two weeks for infections covering antimicrobial drugs. For chronic illnesses, P100 shall be limited to cover two weeks maintenance dose after discharge; for other acute illnesses, P100 drugs shall be limited to one extra pack as take home medications after discharge; and should be within the prescribed in-patient benefit limits for drugs and medicines.

In case the required P100 drugs are unavailable in the accredited hospital where the member is admitted, the purchase of such drugs from any P100 outlets or sources authorized by the DOH like DOH and LGU supervised facilities, Botika ng Bayan outlets, Botika ng Barangay, may be covered provided that corresponding official receipts are attached to the claim application for direct reimbursement to the patient/member subject to the patient benefit ceiling on drugs and medications and filing of claims within the prescribed period of 60 days after discharge.

Claim application for P100 drugs should be incorporated in the claim form 2 part III for the in-patient services.

Medicines available under the P100 DOH Program include Amlodipine 5mg (12 tablets for P100.00); Felodipine 2.5mg (7 tablets for P100.00); Felodipine 5mg (5 tablets for P100.00); Felodipine 10mg (3 tablets for P100.00); Simvastatin 20mg (18 tablets for P100.00); Atenolol 50mg (14 tablets for P100.00); Ascorbic Acid 500mg (30 tablets for P100.00); Omeprazole 20mg (15 tablets for P100.00). (PIA MP) [top]

|«  prev  next  »|
»100 Las Navas youth receive Pangulong Gloria Scholarship vouchers
»DAR part and parcel of economic recovery plan, official says
»Group hails government employees salary adjustment
»ComVal gov turns over checks to primary coops
»Jobs fair, services banner Independence Day celebration in Baguio
»10,198 from Cordillera receive gov't assistance during Independence Day celebration
»Regional rehabilitation center for youth to rise in Sablan
»CADAC's "Sayawit" contest winners bared
»3,931 enroll under TESDA's Pangulong Gloria Scholarship
»Fighting insurgency remains major thrust of Cordillera PNP
|«  prev  next  »|

Philippine Official Gazette | Office of the President | Presidential Communications Operations Office
For comments and feedback, please email PIA Newsdesk
Copyright © 2005 Philippine Information Agency
PIA Building, Visayas Avenue, Diliman, Quezon City 1101 Philippines